找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: New Drug Development; An Introduction to C J. Rick Turner Book 2010Latest edition Springer Science+Business Media, LLC 2010 Clinical.Develo

[復(fù)制鏈接]
樓主: microbe
11#
發(fā)表于 2025-3-23 13:31:22 | 只看該作者
12#
發(fā)表于 2025-3-23 15:11:59 | 只看該作者
introduction to statistics and illustrates its important rolNew Drug Development: Second Edition provides an overview of the design concepts and statistical practices involved in therapeutic drug development. This wide spectrum of activities begins with identifying a potentially useful drug candidat
13#
發(fā)表于 2025-3-23 20:27:58 | 只看該作者
Book 2010Latest editionhis wide spectrum of activities begins with identifying a potentially useful drug candidate that can perhaps be used in the treatment or prevention of a condition of clinical concern, and ends with marketing approval being granted by one or more regulatory agencies. In between, it includes drug mole
14#
發(fā)表于 2025-3-24 01:44:50 | 只看該作者
http://image.papertrans.cn/n/image/665160.jpg
15#
發(fā)表于 2025-3-24 04:20:31 | 只看該作者
16#
發(fā)表于 2025-3-24 09:44:42 | 只看該作者
Statistical Analysis,As noted in Chapter 1, Statistics can be thought of as an integrated discipline that includes several steps:
17#
發(fā)表于 2025-3-24 12:14:50 | 只看該作者
18#
發(fā)表于 2025-3-24 17:03:03 | 只看該作者
Nonclinical Research,egulatory governance, and reports of them are included in regulatory submissions requesting marketing approval. Three areas of investigation are considered here: pharmacokinetics, pharmacology, and toxicology. The scientific rationale of the studies is addressed, along with a summary of appropriate regulatory guidance.
19#
發(fā)表于 2025-3-24 19:38:31 | 只看該作者
Designing Clinical Trials, design, conduct, and analysis impose artificial divisions on a process whose very nature is interactive and integrative. However, there is benefit in looking at components separately, since discussions can temporarily focus on one or two of them before illustrating the interrelatedness of all three. This chapter focuses on study design.
20#
發(fā)表于 2025-3-25 01:08:39 | 只看該作者
Efficacy Assessment,g approval, that is, it needs to have a favorable benefit–risk profile. Therapeutic benefit, operationalized as efficacy, is evaluated in therapeutic exploratory and therapeutic confirmatory trials, trials in which the subjects have the disease or condition of biological concern.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 13:55
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
洪湖市| 南宫市| 通辽市| 敦煌市| 茶陵县| 鲁山县| 和田县| 高清| 江油市| 陆良县| 舞钢市| 波密县| 华坪县| 德兴市| 望谟县| 岱山县| 赫章县| 双峰县| 苏尼特右旗| 宽甸| 利津县| 泊头市| 云南省| 北安市| 雅江县| 广灵县| 洛阳市| 汉源县| 城步| 阜平县| 句容市| 铅山县| 绍兴县| 汉寿县| 阳城县| 贵溪市| 兴海县| 察哈| 绵竹市| 台中县| 苍山县|